Clinical Features and Laboratory Findings of Visceral Leishmaniasis in Children Referred To Children Medical Center Hospital, Tehran, Iran during 2004-2011.

  • Azam Tofighi Naeem Department of Infectious Disease, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Shima Mahmoudi Pediatric Infectious Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Farah Saboui Department of Infectious Disease, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Homa Hajjaran Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Babak Pourakbari Pediatric Infectious Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Mehdi Mohebali Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Mohammad Reza Zarkesh Neonatal Intensive Care Unit, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Setareh Mamishi Department of Infectious Disease, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran AND Pediatric Infectious Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Keywords: Children, Iran, Visceral leishmaniasis

Abstract

 Background: Visceral leishmaniasis (VL) is one of the most important parasitic diseases endemic in northwestern and southern areas of Iran. The aim of the pre-sent study was to review the records of children hospitalized with VL in order to characterize the clinical features of children as well as laboratory finding in Chil-dren Medical Center Hospital, Tehran, Iran. Methods: The medical records of all children with a final diagnosis of VL were reviewed from 2004 to 2011. Demographic, clinical information, laboratory find-ing and treatment were considered. Results: A total number of 34 children with confirmed VL through 2004-2011 were included in the study. The most prevalent sign and symptoms were fever (97.1%), pallor and weakness (97.1%), appetite loss (61.8%), splenomegaly (97.1%) and hepatomegaly (88.2%). The most frequent laboratory abnormalities were hematological including anemia (97.1%), thrombocytopenia (91.2%) and leukopenia (67.6%). Direct agglutination test (DAT) was performed in 23 cases and all of them showed anti-Leishmania antibodies with titers of ≥ 1: 3200. In addition, 90% of patients had positive rK39 results. Identification of Leishmania in the aspirates of the bone marrow was found in 83.3% of patients. Conclusion: Regional surveillance system in order to monitoring of leishmania-sis trends as well as detection of new emerging foci is recommended.

References

Maltezou HC. Drug resistance in visceral leish-maniasis. J Biomed Biotechnol. 2010;20-10:6175212.

Tiuman TS, Santos AO, Ueda-Nakamura T, Nakamura CV. Recent advances in leishmania-sis treatment. Int J Infect Dis. 2011;15: 525-532.

Braga ASdC, Toledo Junior ACdC, Rabello A. Factors of poor prognosis of visceral leishman-iasis among children under 12 years of age: A retrospective monocentric study in Belo Hori-zonte, state of Minas Gerais, Brazil, 2001-2005. Rev Soc Bras Med Trop. 2013;46:55-59.

Desjeux P. Leishmaniasis: Current situation and new perspectives. Comp Immunol Micro-biol Infect Dis. 2004;27:305-318.

Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7: 35671.

Postigo JAR. Leishmaniasis in the world health organization eastern Mediterranean region. Int J Antimicrob Agents. 2010;36 Suppl1: S62-5 7.

Fu Q, Li S-Z, Wu W-P, Hou Y-Y, Zhang S, Feng Y, Zhang L-P, Tang L-H. Endemic char-acteristics of infantile visceral leishmaniasis in the people's republic of china. Parasit Vectors. 2013;6:143.

Mondal D, Singh SP, Kumar N, Joshi A, Sundar S, Das P, Siddhivinayak H, Kroeger A, Boelaert M. Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: Reshaping the case finding/case management strategy. PLoS Negl Trop Dis. 2009;3(1):e355.

Picado A, Dash AP, Bhattacharya S, Boelaert M. Vector control interventions for visceral leishmaniasis elimination initiative in south Asia, 2005-2010. Indian J Med Res. 2012;136(1):22-31.

Srividya G, Kulshrestha A, Singh R, Salotra P. Diagnosis of visceral leishmaniasis: Develop-ments over the last decade. Parasitol Res. 2012;110:1065-1078.

Mohebali M, Edrissian G, Nadim A, Hajjaran H, Akhoundi B, Hooshmand B, Zarei Z, Arshi S, Mirsamadi N, Naeini KM. Application of di-rect agglutination test (DAT) for the diagnosis and seroepidemiological studies of visceralleishmaniasis in iran. Iran J Parasitol. 2006;1(1): 15-25 12.

Ashkan MM, Rahim KM. Visceral leishmania-sis in pediatrics: A study of 367 cases in south-west Iran. Trop Doct. 2008;38:186-188.

Mohebali M. Visceral leishmaniasis in Iran: Review of the epidemiological and clinical fea-tures. Iran J Parasitol. 2013;8(3):348-358.

Babakhan L, Mohebali M, Akhoundi B, Edris-sian GH, Keshavarz H. Rapid detection of Leishmania infantum infection in dogs: A com-parative study using fast agglutination screening test (fast) and direct agglutination test (DAT) in Iran. Parasitol Res. 2009;105:717-720.

Hamzavi Y, Hamzeh B, Mohebali M, Ak-houndi B, Ajhang K, Khademi N, Ghadiri K, Bashiri H, Pajhouhan M. Human visceral leish-maniasis in Kermanshah Province, western Iran, during 2011-2012. Iran J Parasitol. 2012;7(4):49-56.

Mohebali M, Mamishi S, Desjeux P. Evalua-tion of rapid “dipstick rk39” test in diagnosis and serological survey of visceral leishmaniasis in humans and dogs in Iran. Arch Iran Med. 2003; 6 (1): 29 – 31

Mohebali M, Edrissian GH, Shirzadi MR, Ak-houndi B, Hajjaran H, Zarei Z, Molaei S, Shar-ifi I, Mamishi S, Mahmoudvand H. An obser-vational study on the current distribution of visceral leishmaniasis in different geographicalzones of Iran and implication to health policy. Travel Med Infect Dis. 2011;9:67-74.

Salahi-Moghaddam A, Mohebali M, Moshfae A, Habibi M. Ecological study and risk map-ping of visceral leishmaniasis in an endemic ar-ea of Iran based on a geographical information systems approach. Geospat Health. 2010;5:71-77.

Nadim A, Javadian E, Tahvildar-Bidruni Gh MM, Abaei M. Epidemiological aspects of ka-la-azar in Meshkin-Shahr, Iran: Investigation on vectors. Iranian J Publ Health. 1992;21:61-72.

Sundar S, Rai M. Laboratory diagnosis of vis-ceral leishmaniasis. Clin Diagn Lab Immunol. 2002;9:951-958.

Thakur C. Socio-economics of visceral leish-maniasis in Bihar (India). Trans R Soc Trop Med Hyg. 2000;94:156-157.

Chappuis F, Rijal S, Soto A, Menten J, Boelaert M. A meta-analysis of the diagnostic perfor-mance of the direct agglutination test and rk39 dipstick for visceral leishmaniasis. BMJ. 2006;333(7571):723.

Sundar S, Singh R, Maurya R, Kumar B, Chha-bra A, Singh V, Rai M. Serological diagnosis of indian visceral leishmaniasis: Direct agglutina-tion test versus rk39 strip test. Trans R Soc Trop Med Hyg. 2006;100:533-537.

How to Cite
1.
Tofighi Naeem A, Mahmoudi S, Saboui F, Hajjaran H, Pourakbari B, Mohebali M, Zarkesh MR, Mamishi S. Clinical Features and Laboratory Findings of Visceral Leishmaniasis in Children Referred To Children Medical Center Hospital, Tehran, Iran during 2004-2011. IJPA. 9(1):1-.
Section
Articles